β¨ Medicines Distribution Consents
5270 NEW ZEALAND GAZETTE, No. 207 15 DECEMBER 2005
Dated this 1st day of December 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8343
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Enbrel
Active Ingredient: Etanercept 50mg
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach an der Riss, Germany
Product: MonoFIX-VF
Active Ingredient: Factor IX 1,000IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia
Product: MonoFIX-VF
Active Ingredient: Factor IX 500IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia
Dated this 8th day of December 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8345
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Alimta
Active Ingredient: Pemetrexed sodium 713mg equivalent to 500mg pemetrexed
Dosage Form: Powder for infusion
New Zealand Sponsor: Eli Lilly and Company (NZ) Limited
Manufacturer: Lilly France SAS, Fegersheim, France
Dated this 1st day of December 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8342
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Eloxatin
Active Ingredient: Oxaliplatin 100mg
Dosage Form: Powder for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturers: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Laboratoires Thissen SA, Braine-LβAlleud, Belgium
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 207
Gazette.govt.nz —
NZ Gazette 2005, No 207
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare1 December 2005
Medicines Act, New Medicines, Distribution, Enbrel, Etanercept, MonoFIX-VF, Factor IX
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare1 December 2005
Medicines Act, Changed Medicine, Distribution, Alimta, Pemetrexed sodium
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare1 December 2005
Medicines Act, Changed Medicines, Distribution, Eloxatin, Oxaliplatin
- DON MATHESON, Deputy Director-General, Public Health